hengrui glp 1 Pharma's GLP-1R Agonist Patent Disclosure BMS signs $15.2bn R&D alliance

Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

Food and Drug

Full article here: #orthopedics #sportsmedicine #biologics #peptides #medtech #clinicalresearch #innovation #jointpreservation

Does compounded semaglutide expire after 28 days

The booming class of GLP-1 drugs that includes Ozempic and Wegovy is also showing early potential to help with Parkinsons disease, a new study suggests.

The evidence suggests that traditional management strategies focusing on either condition in isolation fall short of addressing the intertwined nature of diabetes and depression